BIOTECH (127) Kenai Therapeutics: Allogeneic iPSC-Induced Neurology Cell Therapy March 12, 2024March 12, 2024
BIOTECH (126) Accent Therapeutics: Small Molecules Targeting RNA-Modifying Protein March 11, 2024March 11, 2024
BIOTECH (125) Bicycle Therapeutics: Bispecific Bicyclic Peptides Platform March 11, 2024March 11, 2024
BIOTECH (123) Curocell: Anbalcabtagene autoleucel is a novel anti-CD-19 CAR-T therapy – 큐로셀 안발셀 March 10, 2024March 10, 2024
BIOTECH (122) Chugai Pharmaceutical – Eli Lilly: Orforglipron – Oral GLP-1R Agonist March 10, 2024March 10, 2024